Institutional Sign In

Go

GlaxoSmithKline Czech Republic - EBIT

GlaxoSmithKline CR`s EBIT reached 89.9 CZK mil in 2017. This is 66.2 % more than in the previous year.

$1.99

Buy EBIT data for GlaxoSmithKline Czech Republic.

$19.99

Buy all data for GlaxoSmithKline Czech Republic.

from $199/month

Buy annual subscriptions for all our products.

 
Company Unit 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Amgen Czech Republic CZK mil ... ... ... ... ...             56.3 35.0 38.9 52.5 44.3    
Bayer Czech Republic CZK mil ... ... ...                 160 104 128 139 164    
GlaxoSmithKline Czech Republic CZK mil ... ... ...                 291 216 169 119 127    
Merck Czech Republic CZK mil ... ...                   65.9 82.5 48.2 52.6 94.7    
Novartis Czech Republic CZK mil                       56.7 64.0 62.4 97.6 111    
Pfizer Czech Republic CZK mil ... ...                   303 63.4 170 170 98.2    
Roche Czech Republic CZK mil ... ... ...                 83.1 69.0 183 134 81.5   ...
Sanofi-Aventis Czech Republic CZK mil ... ... ... ...               82.9 71.4 89.3 9.99 89.5    
Servier Czech Republic CZK mil ... ... ... ... ... ... ... ... ... ... ... ... 17.4 18.1 18.3 20.4    
Walmark CZK mil ... ... ...                 252 57.0 34.1 105 -328